Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2008
05/08/2008US20080107657 Antibodies that bind to an epitope on the huntington's disease protein
05/08/2008US20080107656 Plasmodium specific immunoglobulin for use in prevention and treatment of parasitic infection; parasiticides
05/08/2008US20080107655 Interferon specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases
05/08/2008US20080107654 Immunloglobulin specific for calcium transport membrane protein for use in prevention and treatment of hematological disorders
05/08/2008US20080107651 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection
05/08/2008US20080107647 Methods and Compositions Relating to Ccr5 Antagonist, Inf-Y and Il-13 Induced Inflammation
05/08/2008US20080107645 Antibody raised against a parasitic protozoan isolate; diagnostic assays for the detection of parasites in animals
05/08/2008US20080107643 Transmembrane polypeptide for use in identifying modulators for prevention and treatment of cell proliferative, fibrotic and sclerotic disorders
05/08/2008US20080107642 Antibodies against gpr64 and uses thereof
05/08/2008US20080107605 From a clone comprising complete nucleotide sequence for the expression of the TSH
05/08/2008US20080107602 Neospora caninum isolate
05/08/2008US20080107601 Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's Disease
05/08/2008US20080107598 Conjugating a chelator, ethylenedicysteine to a targeting ligand, glucosamine, deoxyglucose, metronidazole, annexin V, guanine or LHRH; and a metal ion of 99mTc, 68Ga, 188Re or 187Re
05/08/2008US20080107597 Isolation of antibodies that cross-react and neutralize rankl originating from multiple species
05/08/2008US20080107596 Breast cancer specific genes; a polynucleotide, a protein expressed by a polynucleotide, a polynucleotide capable of hybridizing under stringent conditions
05/08/2008US20080107595 Anti-CCR5 antibody
05/08/2008CA2668295A1 Fgfr4 antibodies
05/08/2008CA2668027A1 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs
05/08/2008CA2668017A1 Improved conjugates
05/08/2008CA2667997A1 Humanized anti-factor d antibodies and uses thereof
05/08/2008CA2667970A1 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii)
05/08/2008CA2667859A1 Method for analysis of hepatitis b virus s antigen
05/08/2008CA2667706A1 Compositions and methods for treating ocular diseases and conditions
05/08/2008CA2667594A1 Recombinant antibodies against vascular endothelial growth factor (vegf)
05/08/2008CA2667141A1 Novel polypeptides and uses thereof
05/08/2008CA2664430A1 Immunochemically equivalent hiv drug analogs
05/08/2008CA2664343A1 High affinity human antibodies to human il-4 receptor
05/08/2008CA2663537A1 Il-17 receptor a antigen binding proteins
05/08/2008CA2648921A1 Immunosuppressant binding antibodies and methods of obtaining and using same
05/08/2008CA2634783A1 Anti-hyperproliferative therapies targeting hdgf
05/08/2008CA2634387A1 Novel collection of hcdr3 regions and uses therefor
05/07/2008EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods
05/07/2008EP1918376A1 FGFR4 promotes cancer cell resistance in response to chemotherapeutic drugs
05/07/2008EP1918372A1 Nucleic acid capable of binding to immunoglobulin g and use thereof
05/07/2008EP1918305A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
05/07/2008EP1918304A1 Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II)
05/07/2008EP1918303A2 method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
05/07/2008EP1918302A2 Methods for the identification and the isolation of epitope specific antibodies
05/07/2008EP1917975A1 Novel proteins in Enteroaggregative Escherichia Coli (EAEC) useful for diagnosis and therapy of EAEC infections
05/07/2008EP1917030A2 Immunoconjugate formulations
05/07/2008EP1917023A2 Erythropoietin receptor peptide formulations and uses
05/07/2008EP1756571A4 Real time method of detecting acute inflammatory conditions
05/07/2008EP1601682B1 Compositions and methods for diagnosing prostate cancer
05/07/2008EP1592446B1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries
05/07/2008EP1545602B1 Pharmaceutical compositions comprising an hiv envelope protein and cd4
05/07/2008EP1523572B1 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination
05/07/2008EP1467757B1 Use of antibodies against the muc18 antigen
05/07/2008EP1456651B1 Self-assembly molecules
05/07/2008EP1364026B1 Human g protein-coupled receptor
05/07/2008EP1360208B1 Method for the production of cytotoxic anti-cancer antibodies
05/07/2008EP1126028B1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
05/07/2008EP0991758B1 Smad6 and uses thereof
05/07/2008CN101175856A Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
05/07/2008CN101175855A Anti-MUC1 a/ss antibodies
05/07/2008CN101175771A Antibodies against CCR5 and uses thereof
05/07/2008CN101175765A Method of weak partitioning chromatography
05/07/2008CN101175507A Use of rip in treating staphylococcus aureus infections
05/07/2008CN101175495A Combination therapy
05/07/2008CN101173293A 神经酰胺酶基因 Ceramidase gene
05/07/2008CN101173290A Chemically synthesized HSV1 virus gB glucoprotein extracellular region gene fragment, representation and application of the same
05/07/2008CN101173285A Gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/07/2008CN101173284A Mouse anti-human ester polyoses acceptor antibody chain variable region gene and use thereof
05/07/2008CN101173283A Mouse anti-human ester polyoses acceptor antibody heavy chain variable region gene and use thereof
05/07/2008CN101173279A SCIRR69 gene, regulation BDNF transcription and application in biomedicine research, biological therapeutic research and invention
05/07/2008CN101172998A BASB111 polypeptide and polynucleotide from
05/07/2008CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
05/07/2008CN100386431C Monoclonal antibody against human chemotactic factor
05/07/2008CN100386343C SARS virus S protein and N protein fusion protein, and preparation and use thereof
05/06/2008US7368556 Not pilC or gene involved in biosynthesis of polysaccharide capsule, IgA protease, pilin, protein which binds transferrin orlactoferrin; involved in colonization of nasopharynx or invasion of submucousal space; diagnosis and prevention of meningitis
05/06/2008US7368554 Polynucleotides encoding BSL2v1c2-Ig
05/06/2008US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues
05/06/2008US7368543 Diagnosis and treatment of hepatic disorders
05/06/2008US7368542 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
05/06/2008US7368537 Administering respiratory syncytial virus G protein immunogen or fragment
05/06/2008US7368535 CD200 receptors
05/06/2008US7368533 Recombinant polynucleotide comprising a nucleotide sequence encoding a polypeptide epitope of amino acid sequence, wherein the epitope specifically binds to anitbodies from subjects diagnosed with endometriosis
05/06/2008US7368532 A non-toxic polypeptide containing a binding domain that binds to the neuronal cell and a translocation domain that translocates the therapeutic agent into the neuronal cell; clostridial neurotoxins
05/06/2008US7368530 Human intestinal Npt2B
05/06/2008US7368529 Protein isolated from plants (Moringa) or recombinant DNA; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases
05/06/2008US7368424 peptide antibiotics comprising lysobactin derivatives used for treatment and/or prophylaxis of bacterial infectious diseases; cyclic peptides
05/06/2008US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
05/06/2008US7368259 Method for generating diversity
05/06/2008US7368257 Using b-cell receptors as tool in identifying modulators for prevention and treatment of inflammation, autoimmune, transplant rejection and cancer disorders
05/06/2008US7368256 Antibodies against Stachybotrys chartarum and methods for their use
05/06/2008US7368250 Using monoclonal antibody specific to tumor cell as diagnostic and therapeutic tool in detection and treatment of cancer; immunodiagnostics; immunotherapy
05/06/2008US7368248 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
05/06/2008US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics
05/06/2008US7368237 Kit for screening for an apoptosis modulator; an isolated cell death-related nuclease (CRN)polypeptide or fragment, polynucleotide encoding fragment, and/or orthologs; medical diagnosis; genetic engineering and expression; hybridization
05/06/2008US7368111 Immunoglobulin for use in diagnosis, prevention and treatment of autoimmune, immunological and inflammatory disorders; immunotherapy
05/06/2008US7368110 Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
05/06/2008US7368109 For ameliorating acquired immunodeficiency syndrome (AIDS), an antoimmune disease, or graft rejection
05/06/2008CA2607709A1 Method for producing anti-idiotypic antibodies
05/06/2008CA1341572C Protective antibodies to serotypic determinants of flagellar antigens
05/02/2008WO2008052187A2 Antibodies and immunoconjugates and uses therefor
05/02/2008WO2008052030A2 A method for increasing antibody-dependent cytotoxicity with castanospermine
05/02/2008WO2008051980A2 Methods of reducing phosphate absorption
05/02/2008WO2008051977A2 Methods of reducing phosphate absorption
05/02/2008WO2008051505A2 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
05/02/2008WO2008051448A2 Methods and compositions for efficient removal of protein a from binding molecule preparations
05/02/2008WO2008050907A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same